Scottish Enterprise - recognising capabilities in drug discovery and development.
The last few years has seen a rapid growth in life sciences in Scotland, in terms of scientific achievement, business development and expansion of core research facilities and infrastructure. The dramatic increase in investment, both internal and external, underlines the increasing recognition and strength of Scotland's academic research base. This editorial seeks to illustrate this from a personalised medicine perspective, with examples of major initiatives in Scotland in component disciplines such as pharmacogenomics, stem cell science, bioinformatics and systems biology. The scientific advances being made in these and other areas will inevitably result in the identification of new or improved applications of personalised therapies.